Publication | Open Access

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma

Neuro-oncologyNovel TherapyGliomaMedicineImmunologyTherapeutic VaccineGene VectorHigh-grade GliomasCytotoxic Gene TherapyCombined ImmunostimulationOncologyRadiation OncologySafety ProfileViral OncologyCancer-associated Virus